語系:
繁體中文
English
說明(常見問題)
登入
回首頁
切換:
標籤
|
MARC模式
|
ISBD
Functional Dyspepsia = Evidences in ...
~
SpringerLink (Online service)
Functional Dyspepsia = Evidences in Pathophysiology and Treatment /
紀錄類型:
書目-語言資料,印刷品 : Monograph/item
正題名/作者:
Functional Dyspepsia/ edited by Kazunari Tominaga, Hiroaki Kusunoki.
其他題名:
Evidences in Pathophysiology and Treatment /
其他作者:
Tominaga, Kazunari.
面頁冊數:
VIII, 187 p. 61 illus., 46 illus. in color.online resource. :
Contained By:
Springer Nature eBook
標題:
Gastroenterology . -
電子資源:
https://doi.org/10.1007/978-981-13-1074-4
ISBN:
9789811310744
Functional Dyspepsia = Evidences in Pathophysiology and Treatment /
Functional Dyspepsia
Evidences in Pathophysiology and Treatment /[electronic resource] :edited by Kazunari Tominaga, Hiroaki Kusunoki. - 1st ed. 2018. - VIII, 187 p. 61 illus., 46 illus. in color.online resource.
PART I: Etiology.-Chapter 1: Definition & Prevalence -- Chapter 2: Genetic Factor -- Chapter 3: Environmental Factors -- PART II: Pathophysiology -- Chapter 4: Neuro-gastroenterology: Central & Autonomic Nervous System.-Chapter 5: Neuro-gastroenterology: Enteric Nervous System -- Chapter 6: Neuro-gastroenterology: Esophago-gastric Function (Motility) .-Chapter 7: Neuro-Gastroenterology: Gastro-duodenal Function (Motility) and Ultrasonographic Assessment.-Chapter 8: Ghrelin and Functional Dyspepsia -- Chapter 9: Psycho-gastroenterology -- Chapter 10: Visceral Hypersensitivity Through Transient Receptor Potential Vanilloid 1 Channels (TRPV1) in Functional Dyspepsia.-PART III: Treatment.-Chapter 11: Efficacy of Acid Suppression Therapy.-Chapter 12: Prokinetics.-Chapter 13: Herbal Medicine.-PART IV: Recent Special Topics: Future Treatment Possibility -- Chapter 14: Gut Dysbiosis and Its Treatment in Patients with Functional Dyspepsia -- Chapter 15: Visceral Hypersensitivity in Functional Dyspepsia (FD) - Therapeutic Approaches to FD Based on Suppression of Visceral Hypersensitivity -- Chapter 16: Pancreatic Exocrine Function.
The research and outcomes presented in this book gather evidence concerning both the pathogenesis and treatment of functional dyspepsia. It provides the latest information on this common non-organic disease, indicating its characteristic pathogenesis based on the brain-gut interaction and micro-environment and evidence gleaned from clinical treatment. Since the pathogenesis is associated with psychology, neurology, endocrinology and bacteriology in addition to gastroenterological physiology, it is often intractable and finding a suitable treatment rationale is challenging. Furthermore, the pathogenesis varies around the world and the efficacy of treatment using standard drugs varies among different populations worldwide; accordingly, this book highlights evidence gained in clinical trials in Japan. Functional Dyspepsia is a milestone produced by respected experts. Addressing unique topics and new findings of treatment including challenging and/or future rationales, it offers an invaluable resource for general clinicians, gastroenterologists, and basic researchers alike. .
ISBN: 9789811310744
Standard No.: 10.1007/978-981-13-1074-4doiSubjects--Topical Terms:
1254565
Gastroenterology .
LC Class. No.: RC799-869
Dewey Class. No.: 616.33
Functional Dyspepsia = Evidences in Pathophysiology and Treatment /
LDR
:03584nam a22003975i 4500
001
988828
003
DE-He213
005
20200703105152.0
007
cr nn 008mamaa
008
201225s2018 si | s |||| 0|eng d
020
$a
9789811310744
$9
978-981-13-1074-4
024
7
$a
10.1007/978-981-13-1074-4
$2
doi
035
$a
978-981-13-1074-4
050
4
$a
RC799-869
072
7
$a
MJH
$2
bicssc
072
7
$a
MED031000
$2
bisacsh
072
7
$a
MJH
$2
thema
082
0 4
$a
616.33
$2
23
245
1 0
$a
Functional Dyspepsia
$h
[electronic resource] :
$b
Evidences in Pathophysiology and Treatment /
$c
edited by Kazunari Tominaga, Hiroaki Kusunoki.
250
$a
1st ed. 2018.
264
1
$a
Singapore :
$b
Springer Singapore :
$b
Imprint: Springer,
$c
2018.
300
$a
VIII, 187 p. 61 illus., 46 illus. in color.
$b
online resource.
336
$a
text
$b
txt
$2
rdacontent
337
$a
computer
$b
c
$2
rdamedia
338
$a
online resource
$b
cr
$2
rdacarrier
347
$a
text file
$b
PDF
$2
rda
505
0
$a
PART I: Etiology.-Chapter 1: Definition & Prevalence -- Chapter 2: Genetic Factor -- Chapter 3: Environmental Factors -- PART II: Pathophysiology -- Chapter 4: Neuro-gastroenterology: Central & Autonomic Nervous System.-Chapter 5: Neuro-gastroenterology: Enteric Nervous System -- Chapter 6: Neuro-gastroenterology: Esophago-gastric Function (Motility) .-Chapter 7: Neuro-Gastroenterology: Gastro-duodenal Function (Motility) and Ultrasonographic Assessment.-Chapter 8: Ghrelin and Functional Dyspepsia -- Chapter 9: Psycho-gastroenterology -- Chapter 10: Visceral Hypersensitivity Through Transient Receptor Potential Vanilloid 1 Channels (TRPV1) in Functional Dyspepsia.-PART III: Treatment.-Chapter 11: Efficacy of Acid Suppression Therapy.-Chapter 12: Prokinetics.-Chapter 13: Herbal Medicine.-PART IV: Recent Special Topics: Future Treatment Possibility -- Chapter 14: Gut Dysbiosis and Its Treatment in Patients with Functional Dyspepsia -- Chapter 15: Visceral Hypersensitivity in Functional Dyspepsia (FD) - Therapeutic Approaches to FD Based on Suppression of Visceral Hypersensitivity -- Chapter 16: Pancreatic Exocrine Function.
520
$a
The research and outcomes presented in this book gather evidence concerning both the pathogenesis and treatment of functional dyspepsia. It provides the latest information on this common non-organic disease, indicating its characteristic pathogenesis based on the brain-gut interaction and micro-environment and evidence gleaned from clinical treatment. Since the pathogenesis is associated with psychology, neurology, endocrinology and bacteriology in addition to gastroenterological physiology, it is often intractable and finding a suitable treatment rationale is challenging. Furthermore, the pathogenesis varies around the world and the efficacy of treatment using standard drugs varies among different populations worldwide; accordingly, this book highlights evidence gained in clinical trials in Japan. Functional Dyspepsia is a milestone produced by respected experts. Addressing unique topics and new findings of treatment including challenging and/or future rationales, it offers an invaluable resource for general clinicians, gastroenterologists, and basic researchers alike. .
650
0
$a
Gastroenterology .
$3
1254565
650
0
$a
Medicine, Psychosomatic.
$3
635955
650
0
$a
Endocrinology .
$3
1254221
650
1 4
$a
Gastroenterology.
$3
673684
650
2 4
$a
Psychosomatic Medicine.
$3
581443
650
2 4
$a
Endocrinology.
$3
645497
700
1
$a
Tominaga, Kazunari.
$4
edt
$4
http://id.loc.gov/vocabulary/relators/edt
$3
1208794
700
1
$a
Kusunoki, Hiroaki.
$4
edt
$4
http://id.loc.gov/vocabulary/relators/edt
$3
1208795
710
2
$a
SpringerLink (Online service)
$3
593884
773
0
$t
Springer Nature eBook
776
0 8
$i
Printed edition:
$z
9789811310737
776
0 8
$i
Printed edition:
$z
9789811310751
776
0 8
$i
Printed edition:
$z
9789811345623
856
4 0
$u
https://doi.org/10.1007/978-981-13-1074-4
912
$a
ZDB-2-SME
912
$a
ZDB-2-SXM
950
$a
Medicine (SpringerNature-11650)
950
$a
Medicine (R0) (SpringerNature-43714)
筆 0 讀者評論
多媒體
評論
新增評論
分享你的心得
Export
取書館別
處理中
...
變更密碼[密碼必須為2種組合(英文和數字)及長度為10碼以上]
登入